Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Sarcoma 3Osteosarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 56fludarabine phosphate 40Peripheral Blood Stem Cell Transplantation 32Cyclosporine 32Filgrastim 31Busulfan 31Mycophenolic Acid 30Antilymphocyte Serum 28Radiotherapy 27Whole-Body Irradiation 25Melphalan 23Tacrolimus 18Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Methotrexate 16Etoposide 16Cytarabine 9Thiotepa 8sargramostim 6fludarabine 6aldesleukin 6Sirolimus 6Rituximab 6thymoglobulin 5Therapeutics 5Psychiatric Rehabilitation 5Granulocyte Colony-Stimulating Factor 5Doxorubicin 4Vincristine 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × trimetrexate glucuronate × Sarcoma × Clear all
NCT00002738 2013-03-07

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
25 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Sarcoma, Osteosarcoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡